Article

Infographic: Do Formulary Drug Exclusions Save Money as Promised?

Author(s):

Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs.

At the beginning of August, Express Scripts and CVS Health announced formulary exclusions aimed at battling rising prescription drug prices. Notably, diabetes drugs took a hit with Express Scripts choosing not to cover Victoza and CVS Health announcing is would pull Lantus, along with its successor Toujeo, in favor of the biosimilar Basaglar.

Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs. They found that in most cases, exclusion policies work.

However, while most studies suggested that drug exclusions save money, in some cases savings from less expensive alternatives were offset by other healthcare spending, such as increased office visits or hospitalizations.

Read the full study.

Related Videos
Dr Gerard Criner
Emma Achola-Kothari, PhD
Dr Margrit Wiesendanger
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
2 experts in this video
Dr Emma Achola-Kothani
Christine Funke, MD
5 experts are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo